If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBILB.L Regulatory News (BILB)

  • There is currently no data for BILB

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

5 Apr 2019 07:00

RNS Number : 2133V
Bilby PLC
05 April 2019
 

5 April 2019

Bilby plc

("Bilby" or the "Company")

 

Directorate Change

 

Bilby Plc (AIM:BILB), a leading gas heating, electrical and building services provider is pleased to announce the appointment of David Bullen as Chief Executive Officer ("CEO") who will join the Company on 15 April 2019. Simultaneously David Ellingham, the current CEO of Bilby, is stepping down to pursue other career opportunities.

 

David Bullen joins Bilby from Boleyn International Ltd, a strategic management consultancy he founded in 2016. Mr Bullen brings an impressive track record of creating substantial shareholder value as CEO at Anpario plc. David joined Anpario in 2007, moving on to become COO in 2009. He was the CEO between 2011 and 2016 where he oversaw growth in revenue and profits, delivering a four-fold increase in the share price. Prior to Anpario, David spent eight years at Novartis, where he held several senior positions both in the UK and abroad.

 

Bilby also announces as part of its ongoing efforts to meet the highest Corporate Governance standards, it has commenced a search for an additional Non-Executive Director to further enhance the Board.

 

The Directors look forward to working with David and are confident Bilby will benefit from his considerable experience of running multi-divisional companies.

 

Sangita Shah, Chairman of Bilby Plc, commented:

"We are delighted to announce David Bullen is joining Bilby as CEO. He brings with him significant experience of managing a listed company and an impressive track record of delivering growth and margin enhancement. We believe he is an excellent fit for Bilby and we look forward to working with him, restoring stakeholder confidence in Bilby and strengthening its market position.

 

Since listing in 2015 David Ellingham has served on the Bilby board and has played a key role in the buy and build strategy and successfully acquired four strong businesses. We wish him well in the future."

 

Commenting on his appointment, David Bullen said:

"I am excited to take the helm of a service-led business that has such a breadth of great people as its foundation. The business will continue to focus on providing a best in class service to our customers, driving further efficiencies to improve our operational excellence and capitalising on the vast potential our sector offers. I believe the outlook for the group is positive and I look forward to delivering success for all stakeholders."

 

Schedule 2(g) Disclosures

 

The following information is disclosed pursuant to Rule 17 and Schedule Two Paragraph (g) of the AIM Rules for Companies.

 

David Michael Alexander Bullen, aged 46, has held the following current and previous directorships in the last 5 years:

 

Current directorships and/or partnerships:

Former directorships and/or partnerships (within the last five years):

Boleyn International Ltd

 

Anpario plc

Anpario UK Ltd

Kiotechagil Ltd

Meriden Animal Health Ltd

Orego-Stim Ltd

 

Save as disclosed above, there are no further disclosures required to be made in respect of the appointment under Schedule 2(g) or Rule 17 of the AIM Rules for Companies.

 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014. Market soundings, as defined in MAR, were taken in respect of the share sale with the result that certain persons became aware of inside information, as permitted by MAR. That inside information is set out in this announcement and has been disclosed as soon as possible in accordance with paragraph 7 of article 17 of MAR. Therefore, those persons that received inside information in a market sounding are no longer in possession of inside information relating to the Group and its securities.

 

 

Enquiries

 

Bilby plc

 

David Bullen, Chief Executive Officer

 

 

+44 (0)20 7796 4133

(via Hudson Sandler)

 

 

Canaccord Genuity Ltd (Nominated Adviser and Joint Broker)

+44 (0)20 7523 8000

Corporate Broking:

Bobbie Hilliam

Georgina McCooke

Sales:

Jonathan Barr

 

 

 

Stanford Capital Partners (Joint Broker)

Patrick Claridge

 

Sales:

John Howes

Bob Pountney

 

+44 (0)20 3815 8880

 

 

Hudson Sandler (Financial PR)

+44 (0)20 7796 4133

Charlie Jack

Bertie Berger

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOADMGGDNDDGLZM
Date   Source Headline
16th Jun 20214:46 pmRNSChange of name to Kinovo plc
24th May 20216:12 pmRNSDirector/PDMR Shareholding
12th May 20214:57 pmRNSDirector/PDMR Shareholding
6th May 202110:09 amRNSHolding(s) in Company
6th May 20217:00 amRNSYear-end trading update
15th Apr 20214:41 pmRNSSecond Price Monitoring Extn
15th Apr 20214:35 pmRNSPrice Monitoring Extension
30th Mar 20217:00 amRNSDirector/PDMR Shareholding
23rd Mar 20214:16 pmRNSHolding(s) in Company
18th Mar 20212:01 pmRNSHolding(s) in Company
12th Mar 20214:41 pmRNSSecond Price Monitoring Extn
12th Mar 20214:36 pmRNSPrice Monitoring Extension
11th Mar 20219:37 amRNSHolding(s) in Company
11th Mar 20219:11 amRNSDirector/PDMR Shareholding and Share Plan
8th Feb 20214:49 pmRNSHolding(s) in Company
28th Jan 20213:58 pmRNSHolding(s) in Company
24th Dec 20207:00 amRNSJoint Share Ownership Plan
1st Dec 20207:00 amRNSHalf Year results
13th Nov 20207:00 amRNSTrading update and Board restructure
14th Oct 20204:40 pmRNSHolding(s) in Company
12th Oct 20208:15 amRNSHolding(s) in Company
5th Oct 202011:04 amRNSReplacement: Holding(s) in Company
30th Sep 202011:33 amRNSHolding(s) in Company
30th Sep 202011:28 amRNSHolding(s) in Company
16th Sep 20206:07 pmRNSDirector/PDMR Shareholding
14th Sep 202011:34 amRNSResult of AGM
11th Sep 202010:07 amRNSBoard change
14th Aug 202011:08 amRNSHolding(s) in Company
14th Aug 202010:35 amRNSAnnual Report and Notice of AGM
27th Jul 20201:27 pmRNSHolding(s) in Company
27th Jul 20207:00 amRNSFull Year Results
16th Jul 20207:00 amRNSNotice of Results
26th May 20208:06 amRNSNew Banking Facilities
7th May 20207:00 amRNSDirector/PDMR Shareholding
28th Apr 20203:44 pmRNSDirector/PDMR Shareholding
24th Apr 20207:00 amRNSYear-end and COVID-19 trading update
1st Apr 20204:41 pmRNSSecond Price Monitoring Extn
1st Apr 20204:36 pmRNSPrice Monitoring Extension
11th Mar 20203:41 pmRNSDirector/PDMR Shareholding
19th Dec 20197:00 amRNSInterim Results
3rd Dec 20194:48 pmRNSNotice of Results
25th Nov 20197:00 amRNSDirectorate Change
22nd Nov 20197:00 amRNSHolding(s) in Company
21st Nov 201912:07 pmRNSHolding(s) in Company
20th Nov 20195:40 pmRNSHolding(s) in Company
20th Nov 20194:40 pmRNSHolding(s) in Company
15th Nov 20198:02 amRNSResult of Fundraise
14th Nov 20194:52 pmRNSProposed Fundraise
28th Oct 20194:21 pmRNSResult of Annual General Meeting
30th Sep 201911:59 amRNSAnnual Report and Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.